Assessment of the effect of interval from presentation to surgery on outcome in patients with peri-ampullary malignancy

HPB

Volumn 18, Issue 4, 2016, Pages 354-359

  Amr, Bassem ^a,b   Shahtahmassebi, Golnaz ^c   Briggs, Christopher D ^a   Bowles, Matthew J ^a   Aroori, Somaiah ^a   Stell, David A ^a,b  

^a DERRIFORD HOSPITAL   (United Kingdom)

^b PLYMOUTH UNIVERSITY PENINSULA SCHOOLS OF MEDICINE AND DENTISTRY   (United Kingdom)

^c NOTTINGHAM TRENT UNIVERSITY   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

ADULT; AGED; ARTICLE; BILE DUCT CANCER; CANCER PATIENT; CANCER STAGING; CANCER SURVIVAL; CLINICAL ASSESSMENT; CONTROLLED STUDY; DIGESTIVE SYSTEM CANCER; DISTAL BILE DUCT CANCER; DISTANT METASTASIS; FACTUAL DATABASE; FEMALE; HEALTH CARE CONCEPTS; HUMAN; INTERVAL FROM PRESENTATION TO SURGERY; MAJOR CLINICAL STUDY; MALE; MEDICAL RECORD REVIEW; OUTCOME ASSESSMENT; OVERALL SURVIVAL; PANCREAS CANCER; PERIAMPULLARY CANCER; RISK REDUCTION; SURVIVAL RATE; SURVIVAL TIME; TUMOR VOLUME; ADENOCARCINOMA; AMPULLA OF VATER; BILE DUCT NEOPLASMS; CHI SQUARE DISTRIBUTION; COMPARATIVE STUDY; DUODENAL NEOPLASMS; KAPLAN MEIER METHOD; MIDDLE AGED; MINIMAL RESIDUAL DISEASE; MORTALITY; MULTIVARIATE ANALYSIS; ODDS RATIO; PANCREATIC NEOPLASMS; PATHOLOGY; PROPORTIONAL HAZARDS MODEL; RISK FACTOR; STATISTICAL MODEL; TIME FACTOR; TIME TO TREATMENT; TREATMENT OUTCOME; VERY ELDERLY;

ADENOCARCINOMA; ADULT; AGED; AGED, 80 AND OVER; AMPULLA OF VATER; BILE DUCT NEOPLASMS; CHI-SQUARE DISTRIBUTION; DATABASES, FACTUAL; DUODENAL NEOPLASMS; FEMALE; HUMANS; KAPLAN-MEIER ESTIMATE; LOGISTIC MODELS; MALE; MIDDLE AGED; MULTIVARIATE ANALYSIS; NEOPLASM, RESIDUAL; ODDS RATIO; PANCREATIC NEOPLASMS; PROPORTIONAL HAZARDS MODELS; RISK FACTORS; TIME FACTORS; TIME-TO-TREATMENT; TREATMENT OUTCOME;

EID: 84976385447     PISSN: 1365182X     EISSN: 14772574     Source Type: Journal    
DOI: 10.1016/j.hpb.2015.10.013     Document Type: Article

References (26)

1. 1 Chen, S.C., Shyr, Y.M., Wang, S.E., Longterm survival after pancreaticoduodenectomy for periampullary adenocarcinomas. HPB Off J Int Hepato Pancreato Biliary Assoc 15 (2013), 951–957.
2. 2 Cleary, S.P., Gryfe, R., Guindi, M., Greig, P., Smith, L., Mackenzie, R., et al. Prognostic factors in resected pancreatic adenocarcinoma: analysis of actual 5-year survivors. JACS 198 (2004), 722–731.
3. 3 Yeo, C.J., Sohn, T.A., Cameron, J.L., Hruban, R.H., Lillemoe, K.D., Pitt, H.A., Periampullary adenocarcinoma: analysis of 5-year survivors. Ann Surg 227 (1998), 821–831.
4. 4 Sohn, T.A., Yeo, C.J., Cameron, J.L., Koniaris, L., Kaushal, S., Abrams, R.A., et al. Resected adenocarcinoma of the pancreas-616 patients: results, outcomes, and prognostic indicators. JOCS Off J Soc Surg Aliment Tract 4 (2000), 567–579.
5. 5 Riall, T.S., Cameron, J.L., Lillemoe, K.D., Winter, J.M., Campbell, K.A., Hruban, R.H., et al. Resected periampullary adenocarcinoma: 5-year survivors and their 6- to 10-year follow-up. Surgery 140 (2006), 764–772.
6. 6 He, J., Ahuja, N., Makary, M.A., Cameron, J.L., Eckhauser, F.E., Choti, M.A., et al. 2564 resected periampullary adenocarcinomas at a single institution: trends over three decades. HPB Off J Int Hepato Pancreato Biliary Assoc 16 (2014), 83–90.
7. 7 Wagner, M., Redaelli, C., Lietz, M., Seiler, C.A., Friess, H., Buchler, M.W., Curative resection is the single most important factor determining outcome in patients with pancreatic adenocarcinoma. Br J Surg 91 (2004), 586–594.
8. 8 DeOliveira, M.L., Cunningham, S.C., Cameron, J.L., Kamangar, F., Winter, J.M., Lillemoe, K.D., et al. Cholangiocarcinoma: thirty-one-year experience with 564 patients at a single institution. Ann Surg 245 (2007), 755–762.
9. 9 Jang, J.Y., Kim, S.W., Park, D.J., Ahn, Y.J., Yoon, Y.S., Choi, M.G., et al. Actual long-term outcome of extrahepatic bile duct cancer after surgical resection. Ann Surg 241 (2005), 77–84.
10. 10 Department of Health, Referral guidelines for suspected cancer. 2000 Available from: http://www.doh.gov.uk/pub/docs/doh/guidelines.pdf.
11. 11 The Royal College of Pathologists | Publications | Datasets and Tissue pathways for gastrointestinal and pancreatobiliary pathology 2009 [cited 2015 18.05.2015]. Available from: http://www.rcpath.org/publications-media/publications/datasets.
12. 12 Chauhan A, Pai C, Binu V. Clinical profile of patients with periampullary carcinoma. GCR. 2010 (Suppl. 1):S28.
13. 13 DiMagno, E.P., Pancreatic cancer: clinical presentation, pitfalls and early clues. Ann Oncol 10:Suppl. 4 (1999), 140–142.
14. 14 Roque, J., Ho, S.H., Goh, K.L., Preoperative drainage for malignant biliary strictures: is it time for self-expanding metallic stents?. Clin Endosc 48 (2015), 8–14.
15. 15 Pomianowska, E., Grzyb, K., Westgaard, A., Clausen, O.P., Gladhaug, I.P., Reclassification of tumour origin in resected periampullary adenocarcinomas reveals underestimation of distal bile duct cancer. EJSO 38 (2012), 1043–1050.
16. 16 Katz, M.H., Bouvet, M., Al-Refaie, W., Gilpin, E.A., Moossa, A.R., Non-pancreatic periampullary adenocarcinomas: an explanation for favorable prognosis. Hepato-Gastroenterology 51 (2004), 842–846.
17. 17 Guidelines for the management of patients with pancreatic cancer periampullary and ampullary carcinomas. Gut 54:Suppl. 5 (2005), v1–v16.
18. 18 Beger, H.G., Rau, B., Gansauge, F., Poch, B., Link, K.H., Treatment of pancreatic cancer: challenge of the facts. WJS 27 (2003), 1075–1084.
19. 19 Lu, D.S., Reber, H.A., Krasny, R.M., Kadell, B.M., Sayre, J., Local staging of pancreatic cancer: criteria for unresectability of major vessels as revealed by pancreatic-phase, thin-section helical CT. AJR 168 (1997), 1439–1443.
20. 20 Bluemke, D.A., Cameron, J.L., Hruban, R.H., Pitt, H.A., Siegelman, S.S., Soyer, P., et al. Potentially resectable pancreatic adenocarcinoma: spiral CT assessment with surgical and pathologic correlation. Radiology 197 (1995), 381–385.
21. 21 Duval, J.V., Savas, L., Banner, B.F., Expression of cytokeratins 7 and 20 in carcinomas of the extrahepatic biliary tract, pancreas, and gallbladder. Arch Pathol Lab Med 124 (2000), 1196–1200.
22. 22 Everett, M.T., Intermittent jaundice in ampullary carcinoma. Br J Surg 55 (1968), 557–558.
23. 23 Richards, M.A., Smith, P., Ramirez, A.J., Fentiman, I.S., Rubens, R.D., The influence on survival of delay in the presentation and treatment of symptomatic breast cancer. BJC 79 (1999), 858–864.
24. 24 Myrdal, G.L.M., Hillerdal, G., Lamberg, K., Agustsson, T., Ståhle, E., Effect of delays on prognosis in patients with non-small cell lung cancer. Thorax 59 (2004), 45–49.
25. 25 Bourgade, V., Drouin, S.J., Yates, D.R., Parra, J., Bitker, M.O., Cussenot, O., et al. Impact of the length of time between diagnosis and surgical removal of urologic neoplasms on survival. World J Urol 32 (2014), 475–479.
26. 26 Picozzi, V.J., Delgado, E.C., Neil, N.J., Malpass, T.W., Delay in diagnosis and treatment of pancreas cancer: the experience of a tertiary referral center. 2009, Gastrointestinal Cancers Symposium, San Francisco, California.